Position in APGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,010,003
-$3,725,001 QoQ
Shares Held
35,761
-59.9% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
113,031 | $15,062,511 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
66,983 | $12,544,576 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
242,884 | $11,425,263 | |
| 4 | IMVT |
Immunovant, Inc.
|
277,873 | $10,706,446 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
30,210 | $10,114,005 | |
| 6 | RLAY |
Relay Therapeutics, Inc.
|
506,235 | $9,471,656 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
149,739 | $8,704,328 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
260,070 | $8,129,788 |
All Filings in APGE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,010,003 | 35,761 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,735,004 | 89,229 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,255,361 | 107,107 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,956,608 | 45,052 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,613,578 | 43,190 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,956,507 | 43,190 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,629,427 | 61,788 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,106,367 | 78,942 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,934,329 | 119,403 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||